Cited by 17Hormonal and reproductive studiesMenopause: Health Impacts and TreatmentsEstrogen and related hormone effects

Longitudinal changes in sex hormone binding globulin (SHBG) and risk of incident diabetes: the study of women’s health across the nation (SWAN)

Open access
Hedderson, Monique M., Capra, Angela, Lee, Catherine, Habel, Laurel A., Lee, Jennifer, Gold, Ellen B., Badon, Sylvia E., Mitro, Susanna D. +1 more·2024·Diabetes Care

Abstract

OBJECTIVE: To investigate the associations of longitudinal changes in sex hormone binding globulin (SHBG) and testosterone (T) over the menopause transition with the risk of diabetes. RESEARCH DESIGN AND METHODS: We followed 2,952 participants in the Study of Women’s Health Across the Nation (SWAN) who were premenopausal or early perimenopausal and diabetes-free at baseline. SHBG,T, and estradiol (E2) levels were measured at up to 13 follow-up visits (over up to 17 years). We used complementary log-log–based discrete-time survival models anchored at baseline. RESULTS: Diabetes developed in 376 women. A 5-unit increase in time-varying SHBG was associated with a 10% reduced risk of diabetes (hazard ratio [HR] 0.91, 95% CI 0.87–0.95), adjusting for covariates, and baseline SHBG,T, and E2 levels. Time-varying T was not associated with diabetes risk. Compared with the lowest quartile for annual rate of change of SHBG since baseline (quartile 1 [Q1] −92.3 to −1.5 nmol/L), all other quartiles were associated with a decreased risk of diabetes adjusting for covariates and baseline SHBG; associations persisted after adjusting for rate of change of T and E2 (Q2 [> −1.5 to −0.2 nmol/L] HR 0.33, 95% CI 0.23–0.48; Q3 [> −0.2 to 1.3 nmol/L] HR 0.37, 95% CI 0.25–0.55; Q4 [>1.3 to 82.0 nmol/L] HR 0.43, 95% CI 0.30–0.63). CONCLUSIONS: Increasing levels of SHBG over the menopause transition were associated with a decreased risk of incident diabetes. Stable to increasing rates of change in SHBG were also independently associated with a decreased risk of diabetes compared with decreasing rates of change, suggesting SHBG may affect glucose through a mechanism beyond androgenicity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc23-1630

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Sowers M, Crawford SL, Sternfeld B, et al. SWAN: A Multicenter, Multiethnic, Community- Based Cohort Study of Women and the Menopausal Transition. In: Lobo RA, Kelsey J, Marcus R, Eds. Menopause: Biology and Pathobiology. Cambridge, Academic Press, 2000, pp. 175-188

Cited by

Sorted by citations

Authors
Hedderson, M. M., Capra, A., Lee, C., Habel, L. A., Lee, J., Gold, E. B., Badon, S. E., Mitro, S. D., & El Khoudary, S. R.
Affiliations
  • Kaiser Permanente (US)
  • Stanford University (US)
  • University of California, Davis (US)
  • 4University of Pittsburgh, Pittsburgh, PA
Corresponding author
Hedderson, Monique M.
Venue
Diabetes Care
Published
2024-02-06
Volume
47
Issue
4
Pages
676-682
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4391558569
Cited by
17
References
23
Citations by year
2026: 4 · 2025: 9 · 2024: 4
FWCI
5.60
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (U01AG012495, U01AG012505, U01AG012531, U01AG012535, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U19AG063720)
  • National Institute of Nursing Research (U01NR004061)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
sex hormone-binding globulin, testosterone, diabetes risk, perimenopause, perimenopausal women, estradiol, glucose metabolism, androgenic activity
MeSH terms
Diabetes Mellitus, Estradiol, Female, Humans, Menopause, Sex Hormone-Binding Globulin, Testosterone, Women's Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review